Masipro
Country: European Union
Language: Finnish
Source: EMA (European Medicines Agency)
Public Assessment Report
(PAR)
04-04-2018
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
Masitinib mesilate
Available from:
AB Science
ATC code:
L01XE22
INN (International Name):
masitinib
Therapeutic group:
Antineoplastiset aineet
Therapeutic area:
mastosytoosi
Therapeutic indications:
Hoito mastosytoosi.
Authorization status:
Refused
